• Erin E Hahn, Corrine E Munoz-Plaza, Eric Anthony Lee, Tiffany Q Luong, Brian S Mittman, Michael H Kanter, Hardeep Singh, and Kim N Danforth.
• Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. Erin.E.Hahn@kp.org.
• J Gen Intern Med. 2021 Oct 1; 36 (10): 301530223015-3022.

BackgroundHigh-risk medications pose serious safety risks to older adults, including increasing the risk of falls. Deprescribing potentially inappropriate medications (PIMs) in older adults who have experienced a fall is a key element of fall reduction strategies. However, continued use of PIMs in older adults is common, and clinicians may face substantial deprescribing barriers.ObjectiveExplore patient and clinician experiences with and perceptions of deprescribing PIMs in patients with a history of falls.DesignWe led guided patient feedback sessions to explore deprescribing scenarios with patient stakeholders and conducted semi-structured interviews with primary care physicians (PCPs) to explore knowledge and awareness of fall risk guidelines, deprescribing experiences, and barriers and facilitators to deprescribing.ParticipantsPCPs from Kaiser Permanente Southern California (KPSC) and patient members of the KPSC Regional Patient Advisory Committee.ApproachWe used maximum variation sampling to identify PCPs with patients who had a fall, then categorized the resulting PIM dispense distribution for those patients into high and low frequency. We analyzed the data using a hybrid deductive-inductive approach. Coders applied initial deductively derived codes to the data, simultaneously using an open-code inductive approach to capture emergent themes.Key ResultsPhysicians perceived deprescribing discussions as potentially contentious, even among patients with falls. Physicians reported varying comfort levels with deprescribing strategies: some felt that the conversations might be better suited to others (e.g., pharmacists), while others had well-planned negotiation strategies. Patients reported lack of clarity as to the reasons and goals of deprescribing and poor understanding of the seriousness of falls.ConclusionsOur study suggests that key barriers to deprescribing include PCP trepidation about raising a contentious topic and insufficient patient awareness of the potential seriousness of falls. Findings suggest the need for multifaceted, multilevel deprescribing approaches with clinician training strategies, patient educational resources, and a focus on building trusting patient-clinician relationships.© 2021. Society of General Internal Medicine.

12 keywords...

hide…